Compounds > dehydroepiandrosterone
Page last updated: 2024-08-17

dehydroepiandrosterone and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

dehydroepiandrosterone has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buxton, JR; Dickeson, J; Heller, RF; Smith, BJ1

Other Studies

1 other study(ies) available for dehydroepiandrosterone and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Does beclomethasone dipropionate suppress dehydroepiandrosterone sulphate in postmenopausal women?
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:4

    Topics: Age Distribution; Aged; Asthma; Beclomethasone; Confounding Factors, Epidemiologic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Middle Aged; Postmenopause; Radioimmunoassay; Regression Analysis; Treatment Outcome

1994